Literature DB >> 28801156

Alarming Burden of Triple-Negative Breast Cancer in India.

Krishan K Thakur1, Devivasha Bordoloi1, Ajaikumar B Kunnumakkara2.   

Abstract

Breast cancer is the most prevalent cancer among women worldwide. Among the different breast cancer subtypes, triple-negative breast cancer (TNBC), which is more prevalent among younger age women, is the most aggressive form. Numerous clinicopathologic studies performed throughout the world strongly support the utterly poor prognoses and high recurrence rate of TNBC. The present report details a thorough data survey from Google and PubMed on the burden of TNBC worldwide and other associated factors, with special emphasis on its ever increasing incidence among Indian women. Our analysis revealed that the proportion of TNBC ranges from 6.7% to 27.9% in different countries, with the highest reported percentage in India among all, followed by Indonesia, Algeria, and Pakistan. Most of the other countries (Netherlands, Italy, London, Germany) had a TNBC incidence less than the mean level (ie, 15%). The high incidence of TNBC in the Indian population is associated with vivid risk factors, which primarily include lifestyle, deprivation status, obesity, family history, high mitotic indexes, and BRCA1 mutations. The treatment of TNBC is greatly hampered due to the lack of targeted therapies. Hence, it requires earnest attention towards extensive research for the prevention and development of treatment modalities with high efficacy.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; ER(+); HER(+); India; PR(+); TNBC

Mesh:

Substances:

Year:  2017        PMID: 28801156     DOI: 10.1016/j.clbc.2017.07.013

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  29 in total

Review 1.  Cancer drug development: The missing links.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Bethsebie Lalduhsaki Sailo; Nand Kishor Roy; Krishan Kumar Thakur; Kishore Banik; Mehdi Shakibaei; Subash C Gupta; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2019-04-08

2.  Analysis of pathogenic variants in BRCA1 and BRCA2 genes using next-generation sequencing in women with triple negative breast cancer from South India.

Authors:  Taruna Rajagopal; Arun Seshachalam; Arunachalam Jothi; Krishna Kumar Rathnam; Srikanth Talluri; Sivaramakrishnan Venkatabalasubranian; Nageswara Rao Dunna
Journal:  Mol Biol Rep       Date:  2022-01-12       Impact factor: 2.316

Review 3.  Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC).

Authors:  Aiswarya Chaudhuri; Dulla Naveen Kumar; Deepa Dehari; Sanjay Singh; Pradeep Kumar; Pradeep Kumar Bolla; Dinesh Kumar; Ashish Kumar Agrawal
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-27

4.  Anticancer potential of (-)-epicatechin in a triple-negative mammary gland model.

Authors:  Georgina Almaguer; Pilar Ortiz-Vilchis; Paola Cordero; Rocío Martinez-Vega; Javier Perez-Durán; Eduardo Meaney; Francisco Villarreal; Guillermo Ceballos; Nayelli Nájera
Journal:  J Pharm Pharmacol       Date:  2021-12-07       Impact factor: 4.810

5.  α-Santalol functionalized chitosan nanoparticles as efficient inhibitors of polo-like kinase in triple negative breast cancer.

Authors:  Jinku Zhang; Yanan Wang; Jinmei Li; Wenming Zhao; Zhao Yang; Yanguang Feng
Journal:  RSC Adv       Date:  2020-02-03       Impact factor: 4.036

Review 6.  Mechanistic Involvement of Long Non-Coding RNAs in Oncotherapeutics Resistance in Triple-Negative Breast Cancer.

Authors:  Samarth Kansara; Vijay Pandey; Peter E Lobie; Gautam Sethi; Manoj Garg; Amit Kumar Pandey
Journal:  Cells       Date:  2020-06-21       Impact factor: 6.600

7.  Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer.

Authors:  Apurv Kulkarni; Devaki A Kelkar; Nidhi Parikh; Lingadahalli S Shashidhara; Chaitanyanand B Koppiker; Madhura Kulkarni
Journal:  JCO Glob Oncol       Date:  2020-07

8.  Immunohistochemistry defined subtypes of breast cancer in 678 Sudanese and Eritrean women; hospitals based case series.

Authors:  Asmerom Tesfamariam Sengal; Nada Suliman Haj-Mukhtar; Ahmed Mohammed Elhaj; Shahinaz Bedri; Eva Johanna Kantelhardt; Ahmed A Mohamedani
Journal:  BMC Cancer       Date:  2017-12-01       Impact factor: 4.430

9.  Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients.

Authors:  Sindhu Govindan; Mallikarjuna Siraganahalli Eswaraiah; Chetana Basavaraj; Manjula Adinarayan; Satish Sankaran; Manjiri Bakre
Journal:  BMC Cancer       Date:  2020-08-10       Impact factor: 4.430

10.  Prosopis juliflora (Sw.), DC induces apoptosis and cell cycle arrest in triple negative breast cancer cells: in vitro and in vivo investigations.

Authors:  Bhimashankar Gurushidhappa Utage; Milind Shivajirao Patole; Punam Vasudeo Nagvenkar; Sonali Shankar Kamble; Rajesh Nivarti Gacche
Journal:  Oncotarget       Date:  2018-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.